Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PreBoards > ClinPhar > Flashcards

ClinPhar Flashcards

1
Q

WHICH OF THE FOLLOWING IS NOT A SKILL REQUIRED FOR A CLINICAL PHARMACIST?

A. THERAPEUTIC PLANNING
B. DIAGNOSTIC
C. DRUG MONITORING
D. COMMUNICATION
E. NO CORRECT ANSWER

A

B. DIAGNOSTIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

WHICH OF THE FOLLOWING IS NOT A GOAL OF PHARMACEUTICAL CARE?

A. ELIMINATION OF SYMPTOMS
B. CURE OF DISEASE
C. REDUCTION OF HEALTH CARE COSTS
D. PREVENTION OF DISEASE
E. NO CORRECT ANSWER

A

C. REDUCTION OF HEALTH CARE COSTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

STAGE I HYPERTENSION

A. 120-139 MMHG AND 80-89 MMHG
B. 120-139 MMHG OR 80-89 MMHG
C. 140-159 MMHG OR 90-99 MMLG
D. 140-159 MMHG AND 90-99 MMHG

A

C. 140-159 MMHG OR 90-99 MMLG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

AN ERROR OCCURRED THAT RESULTED IN EITHER AN INITIAL OR PROLONGED HOSPITALIZATION, LEADING TO TEMPPRARY HARM TO THE PATIENT.

A. CAT G
B. CAT H
C. CAT F
D. CAT E

A

C. CAT F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

WHICH OF THE FOLLOWING AREA DOESN’T FOLLOW THE IPPA FORMAT?

A. CHEST
B. ABDOMEN
C. NECK
D. AOTA

A

B. ABDOMEN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ALL ARE TRUE WHEN TAKING FAMILY HISTORY, EXCEPT;

A. ONLY FIRST DEGREE MEMBERS
B. INCLUDE THOSE WHO PASSED AWAY
C. SIBLINGS AND PARENTS HISTORY
D. NO EXCEPTION

A

D. NO EXCEPTION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

THALIDOMIDE WAS FAMOUS IN THE LATE 1950S TO EARLY 60S AS DRUG FOR WHAT?

A. MORNING SICKNESS
B. FLU
C. NERVE DAMAGE
D. PNEUMONIA

A

A. MORNING SICKNESS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

HIRSUTISM FROM MINOXIDIL IS WHAT TYPE OF ADR?

A. TYPE A
B. ТУРЕ B
C. TYPE C
D. TYPE D

A

A. TYPE A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

WHICH OF THE FOLLOWING IS CORRECT FOR STAGE 4 CKD CRCL?

A. eGFR 10-19
B. eGFR 15-29
C. eGFR 30-39
D. eGFR LESS THAN 20

A

B. eGFR 15-29

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

WHICH OF THE FOLLOWING DRUGS DOESN’T REQUIRE TDM?

A. DILTIAZEM
B. PHENYTOIN
C. METHOTREXATE
D. THEOPHYLLINE

A

A. DILTIAZEM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ALSO KNOWN AS LONGITUDINAL STUDY or “PROSPECTIVE STUDY”

A. CROSS SECTIONAL
B. CASE CONTROL
C. COHORT
D. CLINICAL TRIAL

A

C. COHORT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

THE FOLLOWING IS CORRECTLY PAIRED, EXCEPT?

A. LAGUNDI – COUGH
B. SAMBONG – DIURETIC
C. TSAANG GUBAT – ANTIDIARRHEAL
D. BANABA – ANTI-GOUT

A

D. BANABA – ANTI-GOUT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

GOLD STANDARD OF STUDY DESIGNS

A. CROSS SECTIONAL
B. CASE CONTROL
C. COHORT
D. CLINICAL TRIAL

A

D. CLINICAL TRIAL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

COMPONENTS OF EVIDENCE BASED MEDICINE

I. CLINICAL EXPERTISE
II. PATIENT VALUES
III. BEST EVIDENCE
IV. RESEARCH DESIGNS

A. I, II, AND III
B. I, II, AND IV
C. I, II, AND IV
D. I AND III

A

A. I, II, AND III

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

URINE WHEN TAKING STATINS?

A. PALE YELLOW
B. DARK BROWN
C. RED
D. TURBID

A

B. DARK BROWN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

WHICH OF THE FOLLOWING IS CORRECT ARRANGE FROM LEAST TO HIGHEST FORM OF EVIDENCE?

A. RCTs, SYSTEMATIC REVIEWS, META-ANALYSIS
B. COHORT, CASE REPORTS, RCTS
C. OPINION, COHORT, CASE STUDIES
D. ALL ARE CORRECT

A

A. RCTs, SYSTEMATIC REVIEWS, META-ANALYSIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MEASURES CONSEQUENCES IN TERMS OF QUALITY ADJUSTED LIFE YEAR (QALY) GAINED.

A. COST MINIMIZATION
B. COST EFFECTIVENESS
C. COST UTILIZATION
D. COST BENEFIT

A

C. COST UTILIZATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

BLEEDING TYPICALLY ORIGINATES FROM THE UPPER (GI) TRACT, INCLUDING THE MOUTH, ESOPHAGUS, STOMACH, AND THE FIRST PART OF THE SMALL INTESTINES WILL RESULT TO:

A. BLACK, TARRY STOOL
B. REDDISH STOOL
C. DARK BROWN STOOL
D. NO CORRECT ANSWER

A

A. BLACK, TARRY STOOL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

WHICH OF THE FOLLOWING INCREASES DURING PARASITIC INFECTIONS?

A. NEUTROPHILS
B. LYMPHOCYTES
C. EOSINOPHILS
D. BASOPHILS

A

C. EOSINOPHILS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

LDH FRACTION THAT ELEVATES DURING RHABDOMYOLYSIS

A. LDH 1
B. LDH 3
C. LDH 4
D. LDH 2

A

D. LDH 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

WHICH OF THE FOLLOWING DOESN’T LEAD TO DECREASE IN HEMATOCRIT?

A. POLYCETHEMIA VERA
B. HEMOLYSIS
C. OVERHYDRATION
D. BLOOD LOSS

A

A. POLYCETHEMIA VERA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

WARFARIN INHIBITS FORMATION OF CLOTTING FACTORS, EXCEPT;

A. IX
B. X
C. VII
D. III

A

D. III

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

TRUE FOR CARDIAC TROPONIN I

I. PROLONGED ELEVATION
II. MORE SPECIFIC FOR THE HEART
III. INCREASES DURING RHABDOMYOLYSIS
IV. INCREASES DURING MI

A. I, II AND III
B. I, III AND IV
C. I, II AND IV
D. I AND II ONLY

A

C. I, II AND IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

WHICH OF THE FOLLOWING IS BIOLOGICAL PRODUCT COMMONLY GIVEN TO TREAT RHEUMATOID ARTHRITIS?

A. INFLIXIMAB
B. PENICILLAMINE
C. METHOTREXATE
D. SULFASALAZINE

A

A. INFLIXIMAB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

RESPONSIBLE FOR THE COLORATION OF FECES

A. STERCOBILIN
B. UROBILIN
C. UROBILINOGEN
D. NO CORRECT ANSWER

A

A. STERCOBILIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

TRUE FOR CONJUGATED BILIRUBIN, EXCEPT;

A. USUALLY CAUSED BY OBSTRUCTIVE DISEASE
B. WATER SOLUBLE
C. REQUIRE CARRIER FOR TRANSPORT
D. METABOLIZED BY LIVER

A

C. REQUIRE CARRIER FOR TRANSPORT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

WHICH OF THE FOLLOWING IS INCORRECT FOR FBS?

A. REQUIRES FASTING FOR AT LEAST 5 HOURS
B. YOU MAY DRINK WATER DURING THE FASTING TIME
C. MORE THAN 126 MG/DL IS CONSIDERED POSITIVE FOR DM
D. NORMAL READING SHOULD BE BELOW 100 MG/DL

A

A. REQUIRES FASTING FOR AT LEAST 5 HOURS

19
Q

THIS IS THE MOST PREDOMINANT EXTRACELLULAR ANION?

A. PHOSPHATE
B. CHLORIDE
C. SULFATE
D. BICARBONATE

A

B. CHLORIDE

20
Q

CAUSES OF HYPERKALEMIA EXCEPT;

A. K-SPARING DIURETICS
B. NSAIDS
C. KIDNEY FAILURE
D. CALCIUM CHANNEL BLOCKERS

A

D. CALCIUM CHANNEL BLOCKERS

21
Q

WHICH OF THE FOLLOWING CAN BE SEEN IN INCREASE PTH, EXCEPT?

A. ⬆ CA
B. ⬆ РО4
C. ⬇ РО4
D. NO EXCEPTION

A

B. ⬆ РО4

22
Q

WHICH OF THE FOLLOWING STATEMENTS IS INCORRECT FOR HPN?

A. INCREASE IN CARDIAC OUTPUT, INCREASE BLOOD PRESSURE
B. INCREASE IN VASCULAR RESISTANCE, INCREASE BLOOD PRESSURE
C. DECREASE HEART RATE, REDUCE CARDIAC OUTPUT
D. DECREASE STROKE VOLUME, INCREASE BLOOD PRESSURE

A

D. DECREASE STROKE VOLUME, INCREASE BLOOD PRESSURE

23
Q

WHICH OF THE FOLLOWING HAS NO CONTRAINDICATION WITH USE OF BETA BLOCKERS?

A. ELECTROLYTE IMBALANCE
B. ASTHMA
C. DIABETES
D. ARTHRITIS

A

D. ARTHRITIS

24
Q

DRUG OF CHOICE FOR GESTATIONAL HYPERTENSION?

A. NIFEDIPINE
B. METHYLDOPA
C. CAPTOPRIL
D. THIAZIDES

A

B. METHYLDOPA

25
Q

WHAT IS THE 2ND LINE OF TREATMENT FOR TYPE II DM?

A. METFORMIN
B. LIFESTYLE MODIFICATION
C. ADDITION OF SULFONYLUREA
D. NO CORRECT ANSWER

A

A. METFORMIN

26
Q

WHICH IS NOT A COMPLICATION OF DIABETES?

A. RETINOPATHY
B. NEPHROPATHY
C. NEUROPATHY
D. NO CORRECT ANSWER

A

D. NO CORRECT ANSWER

27
Q

CLASSIFICATION OF ASTHMA WHEREIN THERE IS A DAILY EXACERBATIONS

A. MODERATE PERSISTENT
B. MILD PERSISTENT
C. SEVERE PERSISTENT
D. INTERMITTENT

A

MODERATE PERSISTENT

28
Q

WHICH IS NOT A TRIAD OF COPD?

A. EMPHYSEMA
B. BRONCHITIS
C. ASTHMA
D. TUBERCULOSIS

A

D. TUBERCULOSIS

29
Q

TRUE FOR EMPHYSEMA, EXCEPT

A. PINK PUFFERS
B. TISSUE HYPOXIA
C. INCREASE VENTILATION
D. INCREASE CARDIAC OUTPUT

A

D. INCREASE CARDIAC OUTPUT

30
Q

DRUGS TO MANAGE PARKINSON EXCEPT?

A. ANTICHOLINERGICS
B. SELEGILINE
C. AMATIDINE
D. BETA BLOCKER

A

D. BETA BLOCKER

31
Q

CAUSATIVE AGENT/S OF MENINGITIS EXCEPT?

A. NEISSERIA MININGITIDIS
B. STREPTOCOCCUS PNEUMONIAE
C. LISTERIA MONOCYTOGENES
D. NO EXCEPTION

A

D. NO EXCEPTION

32
Q

WHICH OF THE FOLLOWING IS NOT A SKILL REQUIRED FOR A CLINICAL PHARMACIST?

A. DRUG MONITORING
B. NON-DRUG THERAPY
C. COMMUNICATION
D. THERAPEUTIC PLANNING

A

B. NON-DRUG THERAPY

33
Q

ERROR OCCURRED THAT RESULTED IN NEAR DEATH EVENT

A. CAT F
B. CAT I
C. CAT G
D. CAT H

A

D. CAT H

33
Q

WHICH OF THE FOLLOWING AREA DOESN’T FOLLOW THE IPPA FORMAT?

A. CHEST
B. ABDOMEN
C. NECK
D. AOTA

A

B. ABDOMEN

34
Q

A STUDY THAT INCOLVES SURVEYING A SPECIFIC POPULATION FOR THE PREVALENCE OF LUNG CANCER AT A SINGLE POINT IN TIME USES WHAT STUDY DESIGN?

A. COHORT
B. CASE CONTROL
C. RANDOMIZED CONTROL TRIAL
D. CROSS-SECTIONAL

A

D. CROSS-SECTIONAL

35
Q

THE PRINCIPLE BEHIND COMBINATION OF AMOXICILLIN AND CLAVULANIC ACID?

A. SYNERGISM
B. ANTAGONISM
C. ADDITION
D. POTENTIATION

A

D. POTENTIATION

35
Q

WHICH OF THE FOLLOWING MAY CAUSE DRUG-INDUCED KERNICTERUS IN NEONATES?

A. SULFISOXAZOLE
B. ISONIAZID
C. DOXYCYCLINE
D. CHLORAMPHENICOL

A

A. SULFISOXAZOLE

36
Q

THE VITAMIN THAT IS USED FOR HYPERLIPIDEMIA?

A. NIACIN
B. PANTOTHENIC ACID
C. FOLIC ACID
D. BIOTIN

A

A. NIACIN

37
Q

WARFARIN, WHEN TAKEN TOGETHER WITH LEAFY VEGETABLES, RESULTS TO WHICH OF THE FOLLOWING?

I. INCREASE PT-INR
II. DECREASE PT-INR
III. RISK OF BLEEDING
IV. RISK OF THROMBOSIS

A. I AND III
B. II AND IV
C. I AND IV
D. I AND III

A

B. II AND IV

38
Q

THE PHARMACIST WAS REVIEWING A NEW ORDER OF ALDACTONE FOR A PATIENT WHO IS RECEIVING AN ACE INHIBITOR. WHICH OF THE FOLLOWING SIGNIFICANT INTERACTION SHOULD BE NOTED BY THE PHARMACIST?

A. BOTH DRUGS MAY INTERACT TO CAUSE A
DECREASE IN SUGAR LEVELS
B. BOTH DRUGS MAY INTERACT TO CAUSE AN
ELEVATION IN URIC ACID
C. BOTH DRUGS MAY INTERACT TO CAUSE AN
ELEVATION IN BLOOD POTASSIUM LEVELS.
D. ALDACTONE MAY ANTAGONIZE ACE INHIBITOR

A

C. BOTH DRUGS MAY INTERACT TO CAUSE AN
ELEVATION IN BLOOD POTASSIUM LEVELS.

39
Q

A DIABETIC PATIENT WITH HTN IS TAKING ENALAPRIL. HOWEVER, HE COMPLAINED OF SEVERE DRY COUGH WITH THE USE OF THE DRUG. WHICH WOULD BE THE BEST ALTERNATIVE DRUG FOR THE PATIENT?

A. LISINOPRIL
B. NIFEDIPINE
C. THIAZIDE
D. LOSARTAN

A

D. LOSARTAN

40
Q

CHARACTERIZED BY LOW PROTEIN INTAKE WITH ADEQUATE CALORIC INTAKE

A. KWASHIORKOR
B. MARASMUS
C. SECONDARY MALNUTRITION
D. RICKETS

A

A. KWASHIORKOR

40
Q

WHICH OF THE FOLLOWING DEFICIENCIES IS/ARE MOST COMMON CAUSE/S OF MEGALOBLASTIC ANEMIA?

I. IRON DEFICIENCY
II. VITAMIN B12 DEFICIENCY
III. FOLIC ACID DEFICIENCY

A. II
B. II AND III
C. I
D. I, II AND III

A

B. II AND III

41
Q

THE FOLLOWING CAN CAUSE HEMOLYTIC ANEMIA, EXCEPT

A. METHYLDOPA
B. METHYLENE BLUE
C. NAPHTHALENE
D. ACETAMINOPHEN

A

D. ACETAMINOPHEN

41
Q

BETA BLOCKER OVERDOSE MAY LEAD TO BRADYCARDIA. THIS ADVERSE DRUG REACTION CAN BE CLASSIFIED AS

A. TYPE D
B. TYPE B
C. TYPE C
D. TYPE A

A

D. TYPE A

41
Q

THE FOLLOWING OCCURS AT THE THERAPEUTIC DOSE OF THE DRUG EXCEPT:

A. IDIOSYNCRATIC REACTION
B. HYPERSENSITIVITY REACTION
C. SIDE EFFECTS
D. TOXICITY

A

D. TOXICITY

42
Q

METFORMIN, AN ORAL HYPOGLYCEMIC AGENT HAS A PROMINENT SIDE EFFECT WHICH COULD INCREASE LEVELS OF WHAT SUBSTANCE?

A. INSULIN
B. HCl
C. URIC ACID
D. LACTIC ACID

A

D. LACTIC ACID

42
Q

A PATIENT TAKING NONSELECTIVE BETA-BLOCKERS SHOULD NOT BE USED OR SHOULD CAUTIOUSLY USED IN PATIENTS WITH:

A. ALL ARE CORRECT
B. ATRIOVENTRICULAR BLOCK
C. DIABETES
D. ASTHMA

A

A. ALL ARE CORRECT

43
Q

CAUSES OF HYPERKALEMIA, EXCEPT:

A. VASOCONSTRICTORS
B. POTASSIUM SPARING DIURETICS
C. BETA BLOCKERS
D. NSAIDS

A

A. VASOCONSTRICTORS

43
Q

PHASE OF DRUG DEVELOPMENT WHICH ASSESS SAFETY IN HEALTHY HUMAN VOLUNTEERS

A. PHASE 1
B. PHASE 2
C. PRE-CLINICAL
D. PHASE 3

A

A. PHASE 1

44
Q

DRUG OF CHOICE FOR GESTATIONAL HYPERTENSION?

A. CAPTOPRIL
B. NIFEDIPINE
C. THIAZIDES
D. METHYLDOPA

A

D. METHYLDOPA

45
Q

WHICH OF THE FOLLOWING IS BIOLOGICAL PRODUCT COMMONLY GIVEN TO TREAT RHEUMATOID ARTHRITIS?

A. METHOTREXATE
B. PENICILLAMINE
C. SULFASALAZINE
D. INFLIXIMAB

A

D. INFLIXIMAB

46
Q

ALSO KNOWN AS RETROSPECTIVE STUDY

A. CASE CONTROL
B. CLINICAL TRIAL
C. CROSS SECTIONAL
D. COHORT

A

A. CASE CONTROL

47
Q

MAJORITY OF UROBILINOGEN GOES TO

A. SWEAT
B. URINE
C. ENTEROHEPATIC CIRCULATION
D. FECES

A

D. FECES

48
Q

TRUE FOR CONJUGATED BILIRUBIN, EXCEPT:

A. REQUIRE CARRIER FOR TRANSPORT
B. METABOLIZED BY LIVER
C. WATER SOLUBLE
D. USUALLY CAUSED BY OBSTRUCTIVE DISEASE

A

A. REQUIRE CARRIER FOR TRANSPORT

49
Q

TRUE FOR PARKINSON’S DISEASE, EXCEPT:

A. NO EXCEPTION
B. ANTICHOLINERGICS MAY IMPROVE
SYMPTOMS
C. PRESENCE OF RESTING TREMORS
D. SLOW MOVEMENT

A

A. NO EXCEPTION

PreBoards (20 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions